Inserm Transfert, founded in 2000, is the private subsidiary of Inserm, specialized in life sciences technology transfer and collaborative research projects funding. It works under a Public Service Concession Agreement (CSP).
patent families*
number of contracts and licenses*
* For the year 2022
millions of euros invested in Proof of concept
projects detected*
Serving research
The company supports Inserm research units and researchers in the process undertaken to create value from their work. Its actions are part of the translational continuum, from basic and technological research to clinical development, with the aim of creating economic and societal value.
You are
Les 2 consortia COMS@N et COMBio conduits par Inserm Transfert et la
Institutional Partnerships 2023Inserm Transfert annonce la signature d’un accord de collaboration
Industrial Partnerships December 2022Theranexus et Inserm transfert signent une alliance stratégique pour
Industrial Partnerships November 2022Inserm Transfert et PULSALYS signent un accord de partenariat
Institutional Partnerships November 2019